Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

COMBINATION_PRODUCT(1)

1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02602067Phase 1Terminated

131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients

Breast NeoplasmConnective and Soft Tissue NeoplasmDigestive System Neoplasm+6 more

Studychair

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Breast Neoplasms1 Connective and Soft Tissue Neoplasm1 Digestive System Neoplasms1 Head and Neck Neoplasms1 Lymphoma, Non-Hodgkin1 Pancreatic Neoplasms1 Respiratory Tract Neoplasms1 Skin Neoplasms1

Affiliations

ISTITUTO NAZIONALE DEI TUMORI IRCCS - FONDAZIONE "G. PASCALE" NAPLES - ITALY

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Head and Neck Neoplasms

Similarity Score3%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

16 trials

Shared therapeutic areas:

Pancreatic Neoplasms

Similarity Score3%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

12 trials

Shared therapeutic areas:

Pancreatic Neoplasms

Similarity Score3%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

David Cunningham

Royal Marsden NHS Foundation Trust

13 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02602067Phase 1StudyChair

131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients

Breast NeoplasmConnective and Soft Tissue NeoplasmDigestive System Neoplasm+6 more

Terminated

All 1 trials loaded